Crosstalk between the renin–angiotensin, complement and kallikrein–kinin systems in inflammation

Z Bekassy, I Lopatko Fagerström, M Bader… - Nature Reviews …, 2022 - nature.com
During severe inflammatory and infectious diseases, various mediators modulate the
equilibrium of vascular tone, inflammation, coagulation and thrombosis. This Review …

[HTML][HTML] The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease

G Remuzzi, N Perico, M Macia, P Ruggenenti - Kidney International, 2005 - Elsevier
The role of renin-angiotensin-aldosterone system in the progression of chronic kidney
disease The renin-angiotensin-aldosterone system (RAAS) is a well known regulator of …

The incidence and implications of aldosterone breakthrough

AS Bomback, PJ Klemmer - Nature clinical practice Nephrology, 2007 - nature.com
Interruption of the renin–angiotensin–aldosterone system has become a leading therapeutic
strategy in the treatment of chronic heart and kidney disease. Angiotensin-converting …

Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial

S Oparil, SA Yarows, S Patel, H Fang, J Zhang, A Satlin - The Lancet, 2007 - thelancet.com
Background The aim of this study was to assess dual renin system intervention with the
maximum recommended doses of aliskiren and valsartan, compared with each drug alone …

Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase

Z Zhang, Y Zhang, G Ning, DK Deb… - Proceedings of the …, 2008 - National Acad Sciences
The renin–angiotensin system (RAS) plays a critical role in the development of diabetic
nephropathy, and blockade of the RAS is currently used for treatment of diabetic …

Oral renin inhibitors

JA Staessen, Y Li, T Richart - The Lancet, 2006 - thelancet.com
Use of drugs that inhibit the renin-angiotensin system is an effective way to intervene in the
pathogenesis of cardiovascular and renal disorders. The idea of blocking the renin system at …

Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease

CM Ferrario, AE Mullick - Pharmacological research, 2017 - Elsevier
A collective century of discoveries establishes the importance of the renin angiotensin
aldosterone system in maintaining blood pressure, fluid volume and electrolyte homeostasis …

Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide

A Villamil, SG Chrysant, D Calhoun… - Journal of …, 2007 - journals.lww.com
Objectives Aliskiren is a novel, orally active renin inhibitor. Its antihypertensive efficacy and
safety, alone and in combination with hydrochlorothiazide (HCTZ), were investigated in an 8 …

Aliskiren, an oral renin inhibitor, provides dose-dependent efficacy and sustained 24-hour blood pressure control in patients with hypertension

BH Oh, J Mitchell, JR Herron, J Chung, M Khan… - Journal of the American …, 2007 - jacc.org
Objectives: This dose-ranging study evaluated the antihypertensive efficacy and tolerability
of aliskiren in patients with mild-to-moderate hypertension. Background: Low blood pressure …

Renin inhibition with aliskiren: where are we now, and where are we going?

M Azizi, R Webb, J Nussberger… - Journal of …, 2006 - journals.lww.com
With the development of aliskiren, blockade of the renin–angiotensin–aldosterone system
(RAAS) at the level of the interaction of renin with a substrate has become a clinical reality …